Prediction of Cardiac Resynchronization Therapy Response Using a Lead Placement Score Derived From 4-Dimensional Computed Tomography

Cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the treatment. We sought to derive patient-specific left ventricle maps of lead placement scores (LPS) that highlight target pacing lead sites for achieving a...

Full description

Saved in:
Bibliographic Details
Published inCirculation. Cardiovascular imaging Vol. 15; no. 8; p. e014165
Main Authors Manohar, Ashish, Colvert, Gabrielle M, Yang, James, Chen, Zhennong, Ledesma-Carbayo, Maria J, Kronborg, Mads Brix, Sommer, Anders, Nørgaard, Bjarne L, Nielsen, Jens Cosedis, McVeigh, Elliot R
Format Journal Article
LanguageEnglish
Published United States 01.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the treatment. We sought to derive patient-specific left ventricle maps of lead placement scores (LPS) that highlight target pacing lead sites for achieving a higher probability of CRT response. Eighty-two subjects recruited for the ImagingCRT trial (Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy) were retrospectively analyzed. All 82 subjects had 2 contrast-enhanced full cardiac cycle 4-dimensional computed tomography scans: a baseline and a 6-month follow-up scan. CRT response was defined as a reduction in computed tomography-derived end-systolic volume ≥15%. Eight left ventricle features derived from the baseline scans were used to train a support vector machine via a bagging approach. An LPS map over the left ventricle was created for each subject as a linear combination of the support vector machine feature weights and the subject's own feature vector. Performance for distinguishing responders was performed on the original 82 subjects. Fifty-two (63%) subjects were responders. Subjects with an LPS≤Q (lower-quartile) had a posttest probability of responding of 14% (3/21), while subjects with an LPS≥ Q (upper-quartile) had a posttest probability of responding of 90% (19/21). Subjects with Q <LPS<Q had a posttest probability of responding that was essentially unchanged from the pretest probability (75% versus 63%, =0.2). An LPS threshold that maximized the geometric mean of true-negative and true-positive rates identified 26/30 of the nonresponders. The area under the curve of the receiver operating characteristic curve for identifying responders with an LPS threshold was 87%. An LPS map was defined using 4-dimensional computed tomography-derived features of left ventricular mechanics. The LPS correlated with CRT response, reclassifying 25% of the subjects into low probability of response, 25% into high probability of response, and 50% unchanged. These encouraging results highlight the potential utility of 4-dimensional computed tomography in guiding patient selection for CRT. The present findings need verification in larger independent data sets and prospective trials.
AbstractList Background: Cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the treatment. We sought to derive patient-specific left ventricle maps of lead placement scores (LPS) that highlight target pacing lead sites for achieving a higher probability of CRT response. Methods: Eighty-two subjects recruited for the ImagingCRT trial (Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy) were retrospectively analyzed. All 82 subjects had 2 contrast-enhanced full cardiac cycle 4-dimensional computed tomography scans: a baseline and a 6-month follow-up scan. CRT response was defined as a reduction in computed tomography–derived end-systolic volume ≥15%. Eight left ventricle features derived from the baseline scans were used to train a support vector machine via a bagging approach. An LPS map over the left ventricle was created for each subject as a linear combination of the support vector machine feature weights and the subject’s own feature vector. Performance for distinguishing responders was performed on the original 82 subjects. Results: Fifty-two (63%) subjects were responders. Subjects with an LPS≤Q 1 (lower-quartile) had a posttest probability of responding of 14% (3/21), while subjects with an LPS≥ Q 3 (upper-quartile) had a posttest probability of responding of 90% (19/21). Subjects with Q 1 <LPS<Q 3 had a posttest probability of responding that was essentially unchanged from the pretest probability (75% versus 63%, P =0.2). An LPS threshold that maximized the geometric mean of true-negative and true-positive rates identified 26/30 of the nonresponders. The area under the curve of the receiver operating characteristic curve for identifying responders with an LPS threshold was 87%. Conclusions: An LPS map was defined using 4-dimensional computed tomography–derived features of left ventricular mechanics. The LPS correlated with CRT response, reclassifying 25% of the subjects into low probability of response, 25% into high probability of response, and 50% unchanged. These encouraging results highlight the potential utility of 4-dimensional computed tomography in guiding patient selection for CRT. The present findings need verification in larger independent data sets and prospective trials.
Cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the treatment. We sought to derive patient-specific left ventricle maps of lead placement scores (LPS) that highlight target pacing lead sites for achieving a higher probability of CRT response. Eighty-two subjects recruited for the ImagingCRT trial (Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy) were retrospectively analyzed. All 82 subjects had 2 contrast-enhanced full cardiac cycle 4-dimensional computed tomography scans: a baseline and a 6-month follow-up scan. CRT response was defined as a reduction in computed tomography-derived end-systolic volume ≥15%. Eight left ventricle features derived from the baseline scans were used to train a support vector machine via a bagging approach. An LPS map over the left ventricle was created for each subject as a linear combination of the support vector machine feature weights and the subject's own feature vector. Performance for distinguishing responders was performed on the original 82 subjects. Fifty-two (63%) subjects were responders. Subjects with an LPS≤Q (lower-quartile) had a posttest probability of responding of 14% (3/21), while subjects with an LPS≥ Q (upper-quartile) had a posttest probability of responding of 90% (19/21). Subjects with Q <LPS<Q had a posttest probability of responding that was essentially unchanged from the pretest probability (75% versus 63%, =0.2). An LPS threshold that maximized the geometric mean of true-negative and true-positive rates identified 26/30 of the nonresponders. The area under the curve of the receiver operating characteristic curve for identifying responders with an LPS threshold was 87%. An LPS map was defined using 4-dimensional computed tomography-derived features of left ventricular mechanics. The LPS correlated with CRT response, reclassifying 25% of the subjects into low probability of response, 25% into high probability of response, and 50% unchanged. These encouraging results highlight the potential utility of 4-dimensional computed tomography in guiding patient selection for CRT. The present findings need verification in larger independent data sets and prospective trials.
Cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the treatment. We sought to derive patient-specific left ventricle maps of lead placement scores (LPS) that highlight target pacing lead sites for achieving a higher probability of CRT response.BACKGROUNDCardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the treatment. We sought to derive patient-specific left ventricle maps of lead placement scores (LPS) that highlight target pacing lead sites for achieving a higher probability of CRT response.Eighty-two subjects recruited for the ImagingCRT trial (Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy) were retrospectively analyzed. All 82 subjects had 2 contrast-enhanced full cardiac cycle 4-dimensional computed tomography scans: a baseline and a 6-month follow-up scan. CRT response was defined as a reduction in computed tomography-derived end-systolic volume ≥15%. Eight left ventricle features derived from the baseline scans were used to train a support vector machine via a bagging approach. An LPS map over the left ventricle was created for each subject as a linear combination of the support vector machine feature weights and the subject's own feature vector. Performance for distinguishing responders was performed on the original 82 subjects.METHODSEighty-two subjects recruited for the ImagingCRT trial (Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy) were retrospectively analyzed. All 82 subjects had 2 contrast-enhanced full cardiac cycle 4-dimensional computed tomography scans: a baseline and a 6-month follow-up scan. CRT response was defined as a reduction in computed tomography-derived end-systolic volume ≥15%. Eight left ventricle features derived from the baseline scans were used to train a support vector machine via a bagging approach. An LPS map over the left ventricle was created for each subject as a linear combination of the support vector machine feature weights and the subject's own feature vector. Performance for distinguishing responders was performed on the original 82 subjects.Fifty-two (63%) subjects were responders. Subjects with an LPS≤Q1 (lower-quartile) had a posttest probability of responding of 14% (3/21), while subjects with an LPS≥ Q3 (upper-quartile) had a posttest probability of responding of 90% (19/21). Subjects with Q1<LPS<Q3 had a posttest probability of responding that was essentially unchanged from the pretest probability (75% versus 63%, P=0.2). An LPS threshold that maximized the geometric mean of true-negative and true-positive rates identified 26/30 of the nonresponders. The area under the curve of the receiver operating characteristic curve for identifying responders with an LPS threshold was 87%.RESULTSFifty-two (63%) subjects were responders. Subjects with an LPS≤Q1 (lower-quartile) had a posttest probability of responding of 14% (3/21), while subjects with an LPS≥ Q3 (upper-quartile) had a posttest probability of responding of 90% (19/21). Subjects with Q1<LPS<Q3 had a posttest probability of responding that was essentially unchanged from the pretest probability (75% versus 63%, P=0.2). An LPS threshold that maximized the geometric mean of true-negative and true-positive rates identified 26/30 of the nonresponders. The area under the curve of the receiver operating characteristic curve for identifying responders with an LPS threshold was 87%.An LPS map was defined using 4-dimensional computed tomography-derived features of left ventricular mechanics. The LPS correlated with CRT response, reclassifying 25% of the subjects into low probability of response, 25% into high probability of response, and 50% unchanged. These encouraging results highlight the potential utility of 4-dimensional computed tomography in guiding patient selection for CRT. The present findings need verification in larger independent data sets and prospective trials.CONCLUSIONSAn LPS map was defined using 4-dimensional computed tomography-derived features of left ventricular mechanics. The LPS correlated with CRT response, reclassifying 25% of the subjects into low probability of response, 25% into high probability of response, and 50% unchanged. These encouraging results highlight the potential utility of 4-dimensional computed tomography in guiding patient selection for CRT. The present findings need verification in larger independent data sets and prospective trials.
Author Ledesma-Carbayo, Maria J
Colvert, Gabrielle M
Kronborg, Mads Brix
Chen, Zhennong
Nielsen, Jens Cosedis
McVeigh, Elliot R
Yang, James
Manohar, Ashish
Sommer, Anders
Nørgaard, Bjarne L
Author_xml – sequence: 1
  givenname: Ashish
  orcidid: 0000-0001-5239-6260
  surname: Manohar
  fullname: Manohar, Ashish
  organization: Department of Mechanical and Aerospace Engineering (A.M.), University of California San Diego, La Jolla
– sequence: 2
  givenname: Gabrielle M
  surname: Colvert
  fullname: Colvert, Gabrielle M
  organization: Department of Bioengineering (G.M.C., J.Y., Z.C., E.R.M.), University of California San Diego, La Jolla
– sequence: 3
  givenname: James
  orcidid: 0000-0001-7832-277X
  surname: Yang
  fullname: Yang, James
  organization: Department of Bioengineering (G.M.C., J.Y., Z.C., E.R.M.), University of California San Diego, La Jolla
– sequence: 4
  givenname: Zhennong
  orcidid: 0000-0001-6133-8716
  surname: Chen
  fullname: Chen, Zhennong
  organization: Department of Bioengineering (G.M.C., J.Y., Z.C., E.R.M.), University of California San Diego, La Jolla
– sequence: 5
  givenname: Maria J
  surname: Ledesma-Carbayo
  fullname: Ledesma-Carbayo, Maria J
  organization: CIBER-BBN, ISCIII, Madrid, Spain (M.J.L.-C.)
– sequence: 6
  givenname: Mads Brix
  orcidid: 0000-0003-1672-222X
  surname: Kronborg
  fullname: Kronborg, Mads Brix
  organization: Department of Cardiology (M.B.K., B.L.N., J.C.N.), Aarhus University Hospital, Denmark
– sequence: 7
  givenname: Anders
  surname: Sommer
  fullname: Sommer, Anders
  organization: Department of Clinical Medicine (J.C.N.), Aarhus University Hospital, Denmark
– sequence: 8
  givenname: Bjarne L
  surname: Nørgaard
  fullname: Nørgaard, Bjarne L
  organization: Department of Cardiology (M.B.K., B.L.N., J.C.N.), Aarhus University Hospital, Denmark
– sequence: 9
  givenname: Jens Cosedis
  orcidid: 0000-0001-9414-1653
  surname: Nielsen
  fullname: Nielsen, Jens Cosedis
  organization: Department of Cardiology (M.B.K., B.L.N., J.C.N.), Aarhus University Hospital, Denmark
– sequence: 10
  givenname: Elliot R
  orcidid: 0000-0003-1684-2432
  surname: McVeigh
  fullname: McVeigh, Elliot R
  organization: Cardiovascular Division, Department of Medicine (E.R.M.), University of California San Diego, La Jolla
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35973012$$D View this record in MEDLINE/PubMed
BookMark eNpNUctOwzAQtBCI9y8gH7mk2HESN0cUoFQqD0E5R1t7Q40SO9gpUjnz4RgKiNOONDuzjzkg29ZZJOSEsxHnBT-rpg_V9OZ8Mr2djHiajhjPeJFvkX1eZmnC2Jhtf2OelEXO98hBCC-MFYLl412yJ_JSCsbTffJx71EbNRhnqWtoBV4bUPQBw9qqpXfWvMM3OV-ih379xfTOBqRPwdhnCnSGoOl9Cwo7tAN9VM4jvUBv3lDTK-86miUXJnIh2kBLK9f1qyFyc9e55-i5XB-RnQbagMc_9ZA8XV3Oq-tkdjeZVuezRMWFh2SxUBIYlGkKogDNmRJF3uTxwCzCsVCiEalUIAWWEpTSjc44w6yRXMqxRnFITje-vXevKwxD3ZmgsG3BoluFOpVMZFxmooytxaZVeReCx6buvenAr2vO6q8E6n8J1DGBepNAFJ78zFgtOtR_st-Xi08Tk4Zx
CitedBy_id crossref_primary_10_3390_jcm12196212
crossref_primary_10_1007_s10741_023_10357_8
Cites_doi 10.1161/CIRCEP.119.007316
10.1080/24748706.2021.1934617
10.1016/j.hrthm.2017.04.041
10.1016/j.hrthm.2018.04.012
10.1152/ajpheart.2002.282.1.H372
10.1002/jmri.25613
10.1007/BF00994018
10.1161/01.cir.0000035037.11968.5c
10.1161/CIRCULATIONAHA.107.743120
10.1186/1532-429X-12-64
10.1161/JAHA.118.010972
10.1023/A:1007515423169
10.1109/EUSIPCO.2015.7362366
10.1152/ajpheart.1999.276.3.H881
10.1111/jce.14896
10.1093/europace/euy292
10.1002/9781118646106
10.1038/nrcardio.2014.67
10.1002/mrm.1910390402
10.1136/heartjnl-2016-310052
10.1016/j.crvasa.2015.08.001
10.1097/RCT.0000000000000824
10.1161/CIRCULATIONAHA.110.945345
10.1148/radiol.14141578
10.1016/j.jcmg.2011.11.006
10.1016/j.hrthm.2019.03.011
10.1161/CIRCULATIONAHA.106.626143
10.1002/ejhf.530
10.1016/j.jclinepi.2006.01.014
10.1093/bib/bbs006
10.1007/s00259-010-1621-z
10.1093/europace/euu056
10.1002/mp.15709
10.1016/j.hrthm.2019.06.016
10.1016/j.hrthm.2015.10.024
10.1097/RLI.0000000000000601
10.2967/jnumed.111.095448
10.1093/ehjci/jes270
10.1186/1745-6215-14-113
10.1093/eurheartj/ehy546
10.1093/eurheartj/ehw270
10.1161/CIRCULATIONAHA.112.000112
10.1016/j.hrthm.2018.03.020
10.1016/j.jacc.2011.12.030
10.1093/europace/eum133
10.1016/j.euje.2006.12.005
10.1093/europace/eus222
10.1016/j.rcl.2008.10.006
10.1117/1.JMI.6.4.045001
10.1002/mp.15550
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1161/CIRCIMAGING.122.014165
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1942-0080
ExternalDocumentID 10_1161_CIRCIMAGING_122_014165
35973012
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: F31 HL151183
– fundername: NHLBI NIH HHS
  grantid: R01 HL144678
– fundername: NHLBI NIH HHS
  grantid: R01 HL160024
– fundername: NHLBI NIH HHS
  grantid: T32 HL105373
GroupedDBID ---
.XZ
.Z2
0R~
18M
29B
53G
5GY
5VS
6J9
AAAAV
AAHPQ
AAIQE
AAJCS
AARTV
AASCR
ABASU
ABBUW
ABDIG
ABJNI
ABVCZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADGGA
ADHPY
ADNKB
AEBDS
AEETU
AFDTB
AFEXH
AFUWQ
AGINI
AHQNM
AHRYX
AHVBC
AINUH
AJIOK
AJNWD
AJNYG
AJZMW
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
BAWUL
BQLVK
C45
CGR
CS3
CUY
CVF
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
ECM
EEVPB
EIF
EJD
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
H13
HLJTE
HZ~
IKREB
IN~
IPNFZ
KD2
KQ8
KQB
L-C
NPM
O9-
ODMTH
ODZKP
OHYEH
OK1
OPUJH
OUVQU
OVD
OVDNE
OXXIT
P2P
P6G
RAH
RHF
RIG
RLZ
S4S
TEORI
TR2
TSPGW
V2I
W2D
W3M
W8F
WOW
ZZMQN
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c359t-bbc7a0a922a36ad10c365f596540c383c3f327ca73e97accdfd410e4f71778de3
ISSN 1941-9651
1942-0080
IngestDate Sat Aug 17 04:32:01 EDT 2024
Fri Aug 23 01:07:08 EDT 2024
Fri Oct 18 09:11:15 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords four-dimensional computed tomography
heart failure
support vector machine
cardiac resynchronization therapy
heart function tests
ventricular function
cardiac imaging techniques
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c359t-bbc7a0a922a36ad10c365f596540c383c3f327ca73e97accdfd410e4f71778de3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-1672-222X
0000-0003-1684-2432
0000-0001-7832-277X
0000-0001-5239-6260
0000-0001-6133-8716
0000-0001-9414-1653
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/CIRCIMAGING.122.014165
PMID 35973012
PQID 2703417439
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2703417439
crossref_primary_10_1161_CIRCIMAGING_122_014165
pubmed_primary_35973012
PublicationCentury 2000
PublicationDate 2022-08-00
20220801
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation. Cardiovascular imaging
PublicationTitleAlternate Circ Cardiovasc Imaging
PublicationYear 2022
References e_1_3_3_50_2
e_1_3_3_16_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_33_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_40_2
e_1_3_3_5_2
e_1_3_3_7_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_23_2
e_1_3_3_48_2
e_1_3_3_25_2
e_1_3_3_46_2
e_1_3_3_44_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
e_1_3_3_51_2
e_1_3_3_17_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_32_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_6_2
e_1_3_3_8_2
e_1_3_3_28_2
e_1_3_3_49_2
e_1_3_3_24_2
e_1_3_3_47_2
e_1_3_3_26_2
e_1_3_3_45_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_43_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
References_xml – ident: e_1_3_3_22_2
  doi: 10.1161/CIRCEP.119.007316
– ident: e_1_3_3_20_2
  doi: 10.1080/24748706.2021.1934617
– ident: e_1_3_3_15_2
  doi: 10.1016/j.hrthm.2017.04.041
– ident: e_1_3_3_24_2
  doi: 10.1016/j.hrthm.2018.04.012
– ident: e_1_3_3_48_2
  doi: 10.1152/ajpheart.2002.282.1.H372
– ident: e_1_3_3_11_2
  doi: 10.1002/jmri.25613
– ident: e_1_3_3_26_2
  doi: 10.1007/BF00994018
– ident: e_1_3_3_44_2
  doi: 10.1161/01.cir.0000035037.11968.5c
– ident: e_1_3_3_7_2
  doi: 10.1161/CIRCULATIONAHA.107.743120
– ident: e_1_3_3_8_2
  doi: 10.1186/1532-429X-12-64
– ident: e_1_3_3_35_2
  doi: 10.1161/JAHA.118.010972
– ident: e_1_3_3_27_2
  doi: 10.1023/A:1007515423169
– ident: e_1_3_3_28_2
  doi: 10.1109/EUSIPCO.2015.7362366
– ident: e_1_3_3_47_2
  doi: 10.1152/ajpheart.1999.276.3.H881
– ident: e_1_3_3_16_2
  doi: 10.1111/jce.14896
– ident: e_1_3_3_34_2
  doi: 10.1093/europace/euy292
– ident: e_1_3_3_49_2
  doi: 10.1002/9781118646106
– ident: e_1_3_3_3_2
  doi: 10.1038/nrcardio.2014.67
– ident: e_1_3_3_10_2
  doi: 10.1002/mrm.1910390402
– ident: e_1_3_3_46_2
  doi: 10.1136/heartjnl-2016-310052
– ident: e_1_3_3_4_2
  doi: 10.1016/j.crvasa.2015.08.001
– ident: e_1_3_3_17_2
  doi: 10.1097/RCT.0000000000000824
– ident: e_1_3_3_30_2
  doi: 10.1161/CIRCULATIONAHA.110.945345
– ident: e_1_3_3_45_2
  doi: 10.1148/radiol.14141578
– ident: e_1_3_3_29_2
  doi: 10.1016/j.jcmg.2011.11.006
– ident: e_1_3_3_37_2
  doi: 10.1016/j.hrthm.2019.03.011
– ident: e_1_3_3_25_2
  doi: 10.1161/CIRCULATIONAHA.106.626143
– ident: e_1_3_3_19_2
  doi: 10.1002/ejhf.530
– ident: e_1_3_3_50_2
  doi: 10.1016/j.jclinepi.2006.01.014
– ident: e_1_3_3_51_2
  doi: 10.1093/bib/bbs006
– ident: e_1_3_3_33_2
  doi: 10.1007/s00259-010-1621-z
– ident: e_1_3_3_38_2
  doi: 10.1093/europace/euu056
– ident: e_1_3_3_42_2
  doi: 10.1002/mp.15709
– ident: e_1_3_3_36_2
  doi: 10.1016/j.hrthm.2019.06.016
– ident: e_1_3_3_9_2
  doi: 10.1016/j.hrthm.2015.10.024
– ident: e_1_3_3_41_2
  doi: 10.1097/RLI.0000000000000601
– ident: e_1_3_3_31_2
  doi: 10.2967/jnumed.111.095448
– ident: e_1_3_3_12_2
  doi: 10.1093/ehjci/jes270
– ident: e_1_3_3_18_2
  doi: 10.1186/1745-6215-14-113
– ident: e_1_3_3_40_2
  doi: 10.1093/eurheartj/ehy546
– ident: e_1_3_3_23_2
  doi: 10.1093/eurheartj/ehw270
– ident: e_1_3_3_2_2
  doi: 10.1161/CIRCULATIONAHA.112.000112
– ident: e_1_3_3_14_2
  doi: 10.1016/j.hrthm.2018.03.020
– ident: e_1_3_3_5_2
  doi: 10.1016/j.jacc.2011.12.030
– ident: e_1_3_3_32_2
  doi: 10.1093/europace/eum133
– ident: e_1_3_3_6_2
  doi: 10.1016/j.euje.2006.12.005
– ident: e_1_3_3_13_2
  doi: 10.1093/europace/eus222
– ident: e_1_3_3_39_2
  doi: 10.1016/j.rcl.2008.10.006
– ident: e_1_3_3_21_2
  doi: 10.1117/1.JMI.6.4.045001
– ident: e_1_3_3_43_2
  doi: 10.1002/mp.15550
SSID ssj0063058
Score 2.3992307
Snippet Cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the treatment. We...
Background: Cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage e014165
SubjectTerms Cardiac Resynchronization Therapy
Clinical Trials as Topic
Heart Failure - diagnostic imaging
Heart Failure - therapy
Humans
Lipopolysaccharides
Prospective Studies
Retrospective Studies
Tomography
Treatment Outcome
Ventricular Function, Left
Title Prediction of Cardiac Resynchronization Therapy Response Using a Lead Placement Score Derived From 4-Dimensional Computed Tomography
URI https://www.ncbi.nlm.nih.gov/pubmed/35973012
https://www.proquest.com/docview/2703417439/abstract/
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FcuGCithSFg0St8qpxzP22McoQBpQK0CtVHGxZrHVSk2MshzKmb_E_-O9mbGTQECUi2NNovHyvrxtvnmPkNc5-PUc27ezVOWRyCyLtC1kJK3Qhlepzl2JjZPT7PhcvL9IL3q9HxuspdVSD8y3nftK_keqMAZyxV2yt5BsNykMwDnIF44gYTj-k4w_znGZpfX5Rk7YyItf3MyMK3rr91girQJLB-A3SIgFT9NlCBRWV7XYt8i4JCH80Zs58ojmoAIt-LTN9FBEb7D-v6_dcRh6QCD7ZrpZ67otdXA1N6Ed2MDfzgbTder6Ia0z4LPm0pO7h4vLq0WXlR41yNV2pmGsNATy19egeQaddgr5bcfuXXMTvPL8Ap-zJlwkpDIgCm6JdK32LQSLiixUoK3aMfhd7Ns9dSo73YBmvtsSZGgJRpPPo8nJcDw5HQ9YkgyQ1up7U2yX3v7FJHZERRciZazcmKeEeUo_zx1yN5FFikzSD5-6xasMVKjbgdk-TdiYDvMc7b6fbZ_oD4GOc3jO9sn9EKnQoYfdA9KrZg_J9zXkaFPTADn6G-RogBxtIUcd5KiiCDnaQY46yNEAOYqQo1uQoy3k6Bpyj8j5u7dno-MoNPKIDE-LZaS1kSpWRZIoninLYsOztE7h3Qg4zbnhNU-kUZJXhVTG2NoKFleilkzK3Fb8MdkD9FRPCWVpZRNumU5qJmKttcQMRyx0miobW94nR-2rLL_6ei3l34XYJ6_aN16CasX1MjWrmtWiTMAaChex98kTL4puTngutI3Jwa2v94zcW2P_OdlbzlfVC3Bsl_qlg9FP0EejHg
link.rule.ids 315,786,790,27955,27956
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prediction+of+Cardiac+Resynchronization+Therapy+Response+Using+a+Lead+Placement+Score+Derived+From+4-Dimensional+Computed+Tomography&rft.jtitle=Circulation.+Cardiovascular+imaging&rft.au=Manohar%2C+Ashish&rft.au=Colvert%2C+Gabrielle+M.&rft.au=Yang%2C+James&rft.au=Chen%2C+Zhennong&rft.date=2022-08-01&rft.issn=1941-9651&rft.eissn=1942-0080&rft.volume=15&rft.issue=8&rft_id=info:doi/10.1161%2FCIRCIMAGING.122.014165&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_CIRCIMAGING_122_014165
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1941-9651&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1941-9651&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1941-9651&client=summon